Clinical Safety

What Is the Future of JAK Inhibitors in Immune Disease Treatment?
Research & Development What Is the Future of JAK Inhibitors in Immune Disease Treatment?

Evidence from the RA-BEAM and SELECT-COMPARE trials indicates that certain JAK inhibitors can outperform tumor necrosis factor inhibitors in treating rheumatoid arthritis, a landmark finding that has accelerated the transition from traditional injectable biologics to oral small-molecule therapies.

What Is Mosunetuzumab and How Does It Treat Follicular Lymphoma?
Research & Development What Is Mosunetuzumab and How Does It Treat Follicular Lymphoma?

Because mosunetuzumab targets CD20-positive cells, it is essential for clinicians to confirm the biomarker expression on malignant B cells before initiating the immunotherapy. This diagnostic step ensures that patients with relapsed or refractory follicular lymphoma are appropriate candidates for

Can Placental Cell Therapy Heal Chronic Diabetic Foot Ulcers?
Research & Development Can Placental Cell Therapy Heal Chronic Diabetic Foot Ulcers?

The ethical use of healthy, full-term placental tissue provides a unique source of stem-like cells possessing vital immunomodulatory properties for patient safety, and this therapeutic approach has recently gained significant traction as a viable solution for one of the most stubborn challenges in

New Drug Combinations Tackle Tough Co-Infections Effectively
Research & Development New Drug Combinations Tackle Tough Co-Infections Effectively

Recent investigations into clinical isolates have revealed that over half of Pseudomonas aeruginosa strains and three-quarters of Staphylococcus aureus strains exhibit multidrug resistance in hospital settings. This startling reality underscores a burgeoning crisis in modern healthcare, where

Can Stem Cells Improve Survival in Viral Lung Injury?
Research & Development Can Stem Cells Improve Survival in Viral Lung Injury?

A comprehensive meta-analysis of 24 randomized controlled trials indicates that mesenchymal stem cell therapy can reduce the risk of death by 36% in patients suffering from viral lung injury. This revelation comes at a critical time when traditional supportive care often struggles to keep pace with

Is Telehealth Changing How We Treat Presbyopia With Yuvezzi?
Research & Development Is Telehealth Changing How We Treat Presbyopia With Yuvezzi?

Patients using the new telehealth portal can have their presbyopia prescriptions processed and shipped directly to their residences following a successful virtual assessment. For many adults over the age of 45, the sudden inability to focus on a restaurant menu or a smartphone screen represents a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later